CTOs on the Move

option one

www.oohme.com

 
option one is a Corona, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.oohme.com
  • 830 E Parkridge Ave
    Corona, CA USA 92879
  • Phone: 951.273.0190

Executives

Name Title Contact Details

Similar Companies

Bodycad

Bodycad helps healthcare professionals and patients achieve their common pursuit of perfection by actualizing personalized orthopedic restorations. Bodycad enables orthopedic surgeons to create a personalized restoration based on the anatomical specifications of their patient using the company`s proprietary Personalized Restoration Software. Surgeons can quickly and efficiently step through the Bodycad PREP (Personalized Restoration Evaluation Process) to scan their patients and create a specific design plan, approve the design, and perform the restoration. The company is committed to providing high-touch education, training and service, including access to Bodycad PREP Techs to help assure surgical success. Bodycad is transforming the current standard of orthopedic implants to help surgeons and patients achieve their mutual goal of a perfect personalized restoration.

Integrity Medical Devices Inc

Integrity Medical Devices Inc is a Hammonton, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

California Home Medical Eqpt

California Home Medical Eqpt is a San Mateo, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Vivosonic

Vivosonic Inc. is a Etobicoke, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Procyrion

Procyrion is developing the first catheter-deployed circulatory assist device intended for long-term use. The Procyrion device will be the first minimally invasive tool for cardiologists to treat over 1M NYHA Class III and early class IV heart failure (HF) patients in the US who have few therapeutic options. In partnership with Texas Heart Institute, Procyrion is currently conducting preclinical testing of the Procyrion device.